Université de Paris, Faculté de Santé, UFR de Médecine, Paris, France.
AP-HP. Centre-Université de Paris Cité, Hôpital Cochin, Service de Rééducation Et de Réadaptation de L'Appareil Locomoteur Et Des Pathologies du Rachis, 27, Rue du Faubourg Saint-Jacques, 75014, Paris, France.
Eur Radiol. 2023 Jul;33(7):4994-5006. doi: 10.1007/s00330-023-09468-5. Epub 2023 Mar 13.
To describe clinical and early shoulder-girdle MR imaging findings in severe COVID-19-related intensive care unit-acquired weakness (ICU-AW) after ICU discharge.
A single-center prospective cohort study of all consecutive patients with COVID-19-related ICU-AW from November 2020 to June 2021. All patients underwent similar clinical evaluations and shoulder-girdle MRI within the first month and then 3 months (± 1 month) after ICU discharge.
We included 25 patients (14 males; mean [SD] age 62.4 [12.5]). Within the first month after ICU discharge, all patients showed severe proximal predominant bilateral muscular weakness (mean Medical Research Council total score = 46.5/60 [10.1]) associated with bilateral, peripheral muscular edema-like MRI signals of the shoulder girdle in 23/25 (92%) patients. At 3 months, 21/25 (84%) patients showed complete or quasi-complete resolution of proximal muscular weakness (mean Medical Research Council total score > 48/60) and 23/25 (92%) complete resolution of MRI signals of the shoulder girdle, but 12/20 (60%) patients experienced shoulder pain and/or shoulder dysfunction.
Early shoulder-girdle MRI findings in COVID-19-related ICU-AW included muscular edema-like peripheral signal intensities, without fatty muscle involution or muscle necrosis, with favorable evolution at 3 months. Precocious MRI can help clinicians distinguish critical illness myopathy from alternative, more severe diagnoses and can be useful in the care of patients discharged from intensive care with ICU-AW.
• We describe the clinical and shoulder-girdle MRI findings of COVID-19-related severe intensive care unit-acquired weakness. • This information can be used by clinicians to achieve a nearly specific diagnosis, distinguish alternative diagnoses, assess functional prognosis, and select the more appropriate health care rehabilitation and shoulder impairment treatment.
描述 COVID-19 相关重症监护病房获得性肌无力(ICU-AW)后出院后早期的肩部临床和磁共振成像(MRI)表现。
这是一项 2020 年 11 月至 2021 年 6 月间,针对 COVID-19 相关 ICU-AW 的连续患者进行的单中心前瞻性队列研究。所有患者在 ICU 出院后第一个月内和 3 个月(±1 个月)时,均接受类似的临床评估和肩部 MRI。
我们纳入了 25 名患者(男性 14 名;平均年龄 62.4±12.5 岁)。在 ICU 出院后的第一个月内,所有患者均表现出严重的双侧近端肌肉无力(平均医学研究理事会总分 46.5/60[10.1]),23/25(92%)患者双侧、外周肌肉水肿样肩部 MRI 信号。3 个月时,21/25(84%)患者的近端肌肉无力完全或几乎完全缓解(平均医学研究理事会总分>48/60),23/25(92%)患者的肩部 MRI 信号完全缓解,但 12/20(60%)患者出现肩部疼痛和/或肩部功能障碍。
COVID-19 相关 ICU-AW 的早期肩部 MRI 表现包括肌肉水肿样外周信号强度,无脂肪性肌肉萎缩或肌肉坏死,3 个月时可得到良好的恢复。早期 MRI 有助于临床医生鉴别危重病性肌病与其他更严重的诊断,对 ICU-AW 出院患者的治疗和护理具有重要价值。
我们描述了 COVID-19 相关严重 ICU-AW 的临床和肩部 MRI 表现。
这些信息可被临床医生用于做出几乎特异性的诊断,鉴别其他诊断,评估功能预后,并选择更合适的医疗康复和肩部损伤治疗方案。